This Cardiovascular Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The cardiovascular devices market size has grown strongly in recent years. It will grow from $73.14 billion in 2024 to $79.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to lifestyle-related diseases, aging population, minimally invasive procedures and implantable devices, healthcare access, regulatory approvals.
The cardiovascular devices market size is expected to see strong growth in the next few years. It will grow to $102 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to personalized medicine, remote monitoring, emerging markets growth, artificial intelligence (AI) integration, value-based healthcare. Major trends in the forecast period include wearable cardiovascular devices, minimally invasive interventions, bioresorbable devices, remote consultations and telesurgery, sustainable and eco-friendly devices.
The rise in the incidence of cardiovascular disorders is a significant contributing factor to the expansion of the cardiovascular device market. Cardiovascular disorders encompass a range of medical conditions affecting the heart and blood vessels, including various diseases and circulatory system disorders. Cardiovascular devices are used to aid individuals with weak or failing hearts in supporting heart function and blood flow. For example, in June 2023, the Immigration and Checkpoints Authority, a government agency in Singapore, reported 6,884 deaths attributed to heart and hypertensive diseases in 2022, marking a 10.35% increase from the 6,238 deaths recorded in 2021. Hence, the growing prevalence of cardiovascular disorders is poised to stimulate the growth of the cardiovascular device market.
The growing healthcare expenditures are expected to drive the expansion of the cardiovascular device market. Healthcare expenditures encompass the total amount allocated to healthcare-related services, products, and activities over a specified period, often on individual, community, national, or global levels. Increased healthcare spending facilitates the adoption of advanced cardiovascular devices and technologies, resulting in enhanced patient care and outcomes. For example, in May 2023, the Office for National Statistics, a UK-based statistics authority, reported a 9.4% increase in healthcare spending in the UK in nominal terms and a 9.7% increase in real terms. The total healthcare expenditure in the UK in 2021 amounted to $367.25 billion (£280.7 billion), with pharmaceutical expenditure reaching $51.84 billion (£39.6 billion) in 2021. Moreover, spending on preventive care surged to $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Hence, the rise in healthcare expenditure is set to propel the growth of the cardiovascular device market in the future.
Major companies in the cardiovascular devices market are introducing innovative products like the balloon ablation catheter to enhance their market profitability. The balloon ablation catheter is the first radiofrequency balloon ablation catheter designed for catheter-based cardiac electrophysiological mapping, which involves both stimulating and recording the atria. For example, in October 2022, Biosense Webster, a US-based company specializing in diagnosing and treating heart rhythm disorders, launched the HELIOSTAR Balloon Ablation Catheter. This catheter is equipped with unique one-shot balloon technology, enabling pulmonary vein isolation in just 12 seconds. It offers customized energy delivery and integrates a 3D mapping solution for improved performance.
Leadless pacemakers are becoming a viable option for specific medical conditions, particularly bradycardia, due to their minimally invasive nature compared to traditional pacemakers. A leadless pacemaker is a self-contained device that is implanted directly into the right ventricle of the heart, eliminating the need for incisions, leads, or a surgical pocket. Moreover, the implantation procedure for leadless pacemakers is typically completed in under 30 minutes, with minimal post-procedural restrictions. These devices are gaining favor because they reduce complications associated with lead placement, including cardiac perforation, pneumothorax, and lead dislodgement. Medtronic and Abbott are the two major companies involved in the manufacturing of leadless pacemakers.
Major companies operating in the cardiovascular devices market include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton, Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologie Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Danaher Corporation, Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W L Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE and Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc., Nano Therapeutics Pvt. Ltd.
Cardiovascular devices play a crucial role in the monitoring and management of irregular heartbeats and heart rhythm disorders.
The cardiovascular devices market encompasses various key categories, including cardiovascular surgery devices and equipment, cardiac rhythm management (CRM) devices and equipment, interventional cardiology devices and equipment, defibrillator devices and equipment, peripheral vascular devices and equipment, prosthetic heart valve devices and equipment, electrophysiology devices and equipment, as well as cardiac assist devices and equipment. Defibrillators are instrumental devices that restore a normal heartbeat by delivering an electric pulse or shock to the heart. They are utilized to prevent or correct arrhythmias, which involve irregular, slow, or fast heartbeats. The sources of funding for these devices can be either public or private, while the products used include instruments/equipment and disposables. These devices serve a range of end-users, including hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
The cardiovascular devices market research report is one of a series of new reports that provides cardiovascular devices market statistics, including cardiovascular devices industry global market size, regional shares, competitors with a cardiovascular devices market share, detailed cardiovascular devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular devices industry. This cardiovascular devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
North America was the largest region in the global cardiovascular devices market in 2024. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the cardiovascular devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The cardiovascular devices market consists of sales of biventricular devices, and implantable cardiac loop recorders that are used for monitoring and treatment of cardiovascular disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The cardiovascular devices market size has grown strongly in recent years. It will grow from $73.14 billion in 2024 to $79.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to lifestyle-related diseases, aging population, minimally invasive procedures and implantable devices, healthcare access, regulatory approvals.
The cardiovascular devices market size is expected to see strong growth in the next few years. It will grow to $102 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to personalized medicine, remote monitoring, emerging markets growth, artificial intelligence (AI) integration, value-based healthcare. Major trends in the forecast period include wearable cardiovascular devices, minimally invasive interventions, bioresorbable devices, remote consultations and telesurgery, sustainable and eco-friendly devices.
The rise in the incidence of cardiovascular disorders is a significant contributing factor to the expansion of the cardiovascular device market. Cardiovascular disorders encompass a range of medical conditions affecting the heart and blood vessels, including various diseases and circulatory system disorders. Cardiovascular devices are used to aid individuals with weak or failing hearts in supporting heart function and blood flow. For example, in June 2023, the Immigration and Checkpoints Authority, a government agency in Singapore, reported 6,884 deaths attributed to heart and hypertensive diseases in 2022, marking a 10.35% increase from the 6,238 deaths recorded in 2021. Hence, the growing prevalence of cardiovascular disorders is poised to stimulate the growth of the cardiovascular device market.
The growing healthcare expenditures are expected to drive the expansion of the cardiovascular device market. Healthcare expenditures encompass the total amount allocated to healthcare-related services, products, and activities over a specified period, often on individual, community, national, or global levels. Increased healthcare spending facilitates the adoption of advanced cardiovascular devices and technologies, resulting in enhanced patient care and outcomes. For example, in May 2023, the Office for National Statistics, a UK-based statistics authority, reported a 9.4% increase in healthcare spending in the UK in nominal terms and a 9.7% increase in real terms. The total healthcare expenditure in the UK in 2021 amounted to $367.25 billion (£280.7 billion), with pharmaceutical expenditure reaching $51.84 billion (£39.6 billion) in 2021. Moreover, spending on preventive care surged to $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Hence, the rise in healthcare expenditure is set to propel the growth of the cardiovascular device market in the future.
Major companies in the cardiovascular devices market are introducing innovative products like the balloon ablation catheter to enhance their market profitability. The balloon ablation catheter is the first radiofrequency balloon ablation catheter designed for catheter-based cardiac electrophysiological mapping, which involves both stimulating and recording the atria. For example, in October 2022, Biosense Webster, a US-based company specializing in diagnosing and treating heart rhythm disorders, launched the HELIOSTAR Balloon Ablation Catheter. This catheter is equipped with unique one-shot balloon technology, enabling pulmonary vein isolation in just 12 seconds. It offers customized energy delivery and integrates a 3D mapping solution for improved performance.
Leadless pacemakers are becoming a viable option for specific medical conditions, particularly bradycardia, due to their minimally invasive nature compared to traditional pacemakers. A leadless pacemaker is a self-contained device that is implanted directly into the right ventricle of the heart, eliminating the need for incisions, leads, or a surgical pocket. Moreover, the implantation procedure for leadless pacemakers is typically completed in under 30 minutes, with minimal post-procedural restrictions. These devices are gaining favor because they reduce complications associated with lead placement, including cardiac perforation, pneumothorax, and lead dislodgement. Medtronic and Abbott are the two major companies involved in the manufacturing of leadless pacemakers.
Major companies operating in the cardiovascular devices market include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton, Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologie Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Danaher Corporation, Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W L Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE and Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc., Nano Therapeutics Pvt. Ltd.
Cardiovascular devices play a crucial role in the monitoring and management of irregular heartbeats and heart rhythm disorders.
The cardiovascular devices market encompasses various key categories, including cardiovascular surgery devices and equipment, cardiac rhythm management (CRM) devices and equipment, interventional cardiology devices and equipment, defibrillator devices and equipment, peripheral vascular devices and equipment, prosthetic heart valve devices and equipment, electrophysiology devices and equipment, as well as cardiac assist devices and equipment. Defibrillators are instrumental devices that restore a normal heartbeat by delivering an electric pulse or shock to the heart. They are utilized to prevent or correct arrhythmias, which involve irregular, slow, or fast heartbeats. The sources of funding for these devices can be either public or private, while the products used include instruments/equipment and disposables. These devices serve a range of end-users, including hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
The cardiovascular devices market research report is one of a series of new reports that provides cardiovascular devices market statistics, including cardiovascular devices industry global market size, regional shares, competitors with a cardiovascular devices market share, detailed cardiovascular devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular devices industry. This cardiovascular devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
North America was the largest region in the global cardiovascular devices market in 2024. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the cardiovascular devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The cardiovascular devices market consists of sales of biventricular devices, and implantable cardiac loop recorders that are used for monitoring and treatment of cardiovascular disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Executive Summary
Cardiovascular Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on cardiovascular devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiovascular devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiovascular devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Cardiovascular Surgery Devices and Equipment; Cardiac Rhythm Management (CRM) Devices and Equipment; Interventional Cardiology Devices and Equipment; Defibrillator Devices and Equipment; Peripheral Vascular Devices and Equipment; Prosthetic Heart Valve Devices and Equipment; Electrophysiology Devices and Equipment; Cardiac Assist Devices and Equipment2) By End User: Hospitals and Clinics; Diagnostic Laboratories; Other End Users
3) By Type of Expenditure: Public; Private
4) By Product: Instruments or Equipment; Disposables
Subsegments:
1) By Cardiovascular Surgery Devices and Equipment: Coronary Artery Bypass Graft (CABG) Equipment; Heart Valve Repair and Replacement Devices; Aortic Aneurysm Repair Devices; Cardiopulmonary Bypass Equipment; Other Cardiovascular Surgery Devices2) By Cardiac Rhythm Management (CRM) Devices and Equipment: Pacemakers; Defibrillators; Cardiac Resynchronization Therapy (CRT) Devices
3) By Interventional Cardiology Devices and Equipment: Stents (Drug-Eluting, Bare-Metal); Catheters (Balloon, Diagnostic, Guiding); Angioplasty Equipment; Guidewires; Other Interventional Cardiology Devices
4) By Defibrillator Devices and Equipment: Implantable Cardioverter Defibrillators (ICDs); Automated External Defibrillators (AEDs); Wearable Defibrillators; External Defibrillators
5) By Peripheral Vascular Devices and Equipment: Peripheral Stents; Balloons (Peripheral Angioplasty); Embolic Protection Devices; Endovenous Laser Devices; Other Peripheral Vascular Devices
6) By Prosthetic Heart Valve Devices and Equipment: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves (TAVR); Other Prosthetic Heart Valve Devices
7) By Electrophysiology Devices and Equipment: Ablation Catheters; Electrophysiology Mapping Systems; ECG and EKG Systems; Cardiac Mapping and Navigation Systems; Other Electrophysiology Devices
8) By Cardiac Assist Devices and Equipment: Ventricular Assist Devices (LVADs); Intra-Aortic Balloon Pumps; Total Artificial Heart; Extracorporeal Membrane Oxygenation (ECMO); Other Cardiac Assist Devices
Key Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Edwards Lifesciences Corporation; Johnson & Johnson
Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Cardiovascular Devices market report include:- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Edwards Lifesciences Corporation
- Johnson & Johnson
- Terumo Corporation
- Getinge AB
- Teleflex Incorporated
- Becton, Dickinson and Company
- Siemens Healthineers AG
- Fresenius SE & Co. KGaA
- GE HealthCare Technologie Inc.
- Stryker Corporation
- B. Braun Medical Pvt. Ltd.
- Baxter International Inc.
- Danaher Corporation
- Fujifilm Holdings Corporation
- Canon Medical Systems Corporation
- MicroPort Scientific America Inc.
- W L Gore & Associates Inc.
- AngioDynamics Inc.
- CryoLife Inc.
- Endologix LLC
- Lombard Medical Limited
- Avinger Inc.
- Abiomed Inc.
- Biosensors International Group Ltd.
- Biotronik SE and Co. KG
- CeloNova BioSciences Inc.
- LeMaitre Vascular Inc.
- Nano Therapeutics Pvt. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 400 |
| Published | April 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 79.78 Billion |
| Forecasted Market Value ( USD | $ 102 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
